AbCellera Biologics, Inc. (ABCL)
3.62
-0.12
(-3.21%)
USD |
NASDAQ |
Dec 12, 16:00
3.61
-0.01
(-0.28%)
After-Hours: 20:00
AbCellera Biologics Total Liabilities (Quarterly): 222.84M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | 18.42M |
| Oncolytics Biotech, Inc. | 10.74M |
| Aurinia Pharmaceuticals, Inc. | 161.76M |
| Edesa Biotech, Inc. | 0.6727M |
| Lexaria Bioscience Corp. | 1.572M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.356B |
| Shareholders Equity (Quarterly) | 964.04M |
| Debt to Equity Ratio | 0.1475 |
| Current Ratio | 10.10 |
| Net Debt Paydown Yield | -0.93% |